FIGURE

Fig. 4

ID

ZDB-FIG-200406-132

Publication

Almstedt et al., 2020 - Integrative discovery of treatments for high-risk neuroblastoma

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

RNA profiling confirmed modulation of neuroblastoma risk signatures.

a Experiment concept. b Principal component analysis of results for patient 1 (NB-PDX2). Note similar directions of PI3K and MTOR inhibitors omipalisib (OM) and torin-2 (TO) along PC1, and differentiation-inducing agents retinoic acid and JQ1 along PC 4. See also Supplementary Fig. 3. c ROC curve analysing the predictive power of TargetTranslator, defined as the ability to predict (from the public data sources) whether a particular gene signature will decrease (blue) or increase (red) after drug treatment; showing average for 10 risk signatures and all tested drugs, overall area under the curve correctness of 0.916. d Gene Set Enrichment Analysis (GSEA) of drug-induced changes, showing suppressed (blue) and induced (red) pathways. Yellow circles mark the known action of each corresponding drug.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Nat. Commun.